J A Dominguez Rieg1, J M Burt, P Ruth, T Rieg. 1. Department of Basic Sciences, Bastyr University California, San Diego, CA, USA; VA San Diego Healthcare System, San Diego, CA, USA.
Abstract
AIMS: Nucleotides are important paracrine regulators of vascular tone. We previously demonstrated that activation of P2Y₂ receptors causes an acute, NO-independent decrease in blood pressure, indicating this signalling pathway requires an endothelial-derived hyperpolarization (EDH) response. To define the mechanisms by which activation of P2Y₂ receptors initiates EDH and vasodilation, we studied intermediate-conductance (KCa3.1, expressed in endothelial cells) and big-conductance potassium channels (KCa1.1, expressed in smooth muscle cells) as well as components of the myoendothelial gap junction, connexins 37 and 40 (Cx37, Cx40), all hypothesized to be part of the EDH response. METHODS: We compared the effects of a P2Y₂/₄ receptor agonist in wild-type (WT) mice and in mice lacking KCa3.1, KCa1.1, Cx37 or Cx40 under anaesthesia, while monitoring intra-arterial blood pressure and heart rate. RESULTS: Acute activation of P2Y₂/₄ receptors (0.01-3 mg kg(-1) body weight i.v.) caused a biphasic blood pressure response characterized by a dose-dependent and rapid decrease in blood pressure in WT (maximal response % of baseline at 3 mg kg(-1) : -38 ± 1%) followed by a consecutive increase in blood pressure (+44 ± 11%). The maximal responses in KCa3.1(-/-) and Cx37(-/-) were impaired (-13 ± 5, +17 ± 7 and -27 ± 1, +13 ± 3% respectively), whereas the maximal blood pressure decrease in response to acetylcholine at 3 μg kg(-1) was not significantly different (WT: -53 ± 3%; KCa3.1(-/-) : -52 ± 3; Cx37(-/-) : -53 ± 3%). KCa1.1(-/-) and Cx40(-/-) showed an identical biphasic response to P2Y2/4 receptor activation compared to WT. CONCLUSIONS: The data suggest that the P2Y2/4 receptor activation elicits blood pressure responses via distinct mechanisms involving KCa3.1 and Cx37.
AIMS: Nucleotides are important paracrine regulators of vascular tone. We previously demonstrated that activation of P2Y₂ receptors causes an acute, NO-independent decrease in blood pressure, indicating this signalling pathway requires an endothelial-derived hyperpolarization (EDH) response. To define the mechanisms by which activation of P2Y₂ receptors initiates EDH and vasodilation, we studied intermediate-conductance (KCa3.1, expressed in endothelial cells) and big-conductance potassium channels (KCa1.1, expressed in smooth muscle cells) as well as components of the myoendothelial gap junction, connexins 37 and 40 (Cx37, Cx40), all hypothesized to be part of the EDH response. METHODS: We compared the effects of a P2Y₂/₄ receptor agonist in wild-type (WT) mice and in mice lacking KCa3.1, KCa1.1, Cx37 or Cx40 under anaesthesia, while monitoring intra-arterial blood pressure and heart rate. RESULTS: Acute activation of P2Y₂/₄ receptors (0.01-3 mg kg(-1) body weight i.v.) caused a biphasic blood pressure response characterized by a dose-dependent and rapid decrease in blood pressure in WT (maximal response % of baseline at 3 mg kg(-1) : -38 ± 1%) followed by a consecutive increase in blood pressure (+44 ± 11%). The maximal responses in KCa3.1(-/-) and Cx37(-/-) were impaired (-13 ± 5, +17 ± 7 and -27 ± 1, +13 ± 3% respectively), whereas the maximal blood pressure decrease in response to acetylcholine at 3 μg kg(-1) was not significantly different (WT: -53 ± 3%; KCa3.1(-/-) : -52 ± 3; Cx37(-/-) : -53 ± 3%). KCa1.1(-/-) and Cx40(-/-) showed an identical biphasic response to P2Y2/4 receptor activation compared to WT. CONCLUSIONS: The data suggest that the P2Y2/4 receptor activation elicits blood pressure responses via distinct mechanisms involving KCa3.1 and Cx37.
Authors: Pieter-Jan D F Guns; András Korda; Herta M Crauwels; Tim Van Assche; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult Journal: Br J Pharmacol Date: 2005-09 Impact factor: 8.739
Authors: Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult Journal: Br J Pharmacol Date: 2006-03 Impact factor: 8.739
Authors: Jennifer S Fang; Stoyan N Angelov; Alexander M Simon; Janis M Burt Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-19 Impact factor: 4.733
Authors: Ted Begenisich; Tesuji Nakamoto; Catherine E Ovitt; Keith Nehrke; Carlo Brugnara; Seth L Alper; James E Melvin Journal: J Biol Chem Date: 2004-09-03 Impact factor: 5.157
Authors: Gilles Kauffenstein; Annick Drouin; Nathalie Thorin-Trescases; Hélène Bachelard; Bernard Robaye; Pedro D'Orléans-Juste; François Marceau; Eric Thorin; Jean Sévigny Journal: Cardiovasc Res Date: 2010-01-01 Impact factor: 10.787
Authors: Kweonsik Min; Ricardo Munarriz; Benjamin R Yerxa; Irwin Goldstein; Sammy R Shaver; Matthew S Cowlen; Abdulmaged M Traish Journal: Fertil Steril Date: 2003-02 Impact factor: 7.329
Authors: Robert A Fenton; Søren B Poulsen; Samantha de la Mora Chavez; Manoocher Soleimani; Jessica A Dominguez Rieg; Timo Rieg Journal: Kidney Int Date: 2017-04-03 Impact factor: 10.612
Authors: Mazen Shihan; Tatyana Novoyatleva; Thilo Lehmeyer; Akylbek Sydykov; Ralph T Schermuly Journal: Int J Environ Res Public Health Date: 2021-10-20 Impact factor: 3.390
Authors: Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya Journal: Int J Mol Sci Date: 2020-09-18 Impact factor: 5.923